@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ns1: <http://purl.org/spar/pro/> .
@prefix ns2: <http://purl.org/spar/datacite/> .
@prefix ns3: <http://prismstandard.org/namespaces/basic/2.0/> .
@prefix ns4: <http://purl.org/vocab/frbr/core#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<> dcterms:license <https://creativecommons.org/publicdomain/zero/1.0/legalcode> .

<https://w3id.org/oc/meta/br/06604639720> a <http://purl.org/spar/fabio/Expression>,
        <http://purl.org/spar/fabio/JournalArticle> ;
    rdfs:label "br 06604639720" ;
    ns3:publicationDate "2024-01-15"^^xsd:date ;
    dcterms:title "A Randomised Phase II Trial Of Temozolomide With Or Without Cannabinoids In Patients With Recurrent Glioblastoma (ARISTOCRAT): Protocol For A Multi-Centre, Double-Blind, Placebo-Controlled Trial" ;
    ns2:hasIdentifier <https://w3id.org/oc/meta/id/06033903106>,
        <https://w3id.org/oc/meta/id/06606374204> ;
    ns1:isDocumentContextFor <https://w3id.org/oc/meta/ar/066018336442>,
        <https://w3id.org/oc/meta/ar/066018336443>,
        <https://w3id.org/oc/meta/ar/066018336444>,
        <https://w3id.org/oc/meta/ar/066018336445>,
        <https://w3id.org/oc/meta/ar/066018336446>,
        <https://w3id.org/oc/meta/ar/066018336447>,
        <https://w3id.org/oc/meta/ar/066018336448>,
        <https://w3id.org/oc/meta/ar/066018336449>,
        <https://w3id.org/oc/meta/ar/066018336450>,
        <https://w3id.org/oc/meta/ar/066018336451>,
        <https://w3id.org/oc/meta/ar/066018336452>,
        <https://w3id.org/oc/meta/ar/066018336453>,
        <https://w3id.org/oc/meta/ar/066018336454> ;
    ns4:partOf <https://w3id.org/oc/meta/br/06604639867> .